Compare ECOR & ATCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ECOR | ATCH |
|---|---|---|
| Founded | 2005 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.1M | 46.0M |
| IPO Year | 2018 | 2024 |
| Metric | ECOR | ATCH |
|---|---|---|
| Price | $7.08 | $0.28 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $18.00 | $1.00 |
| AVG Volume (30 Days) | 52.1K | ★ 3.9M |
| Earning Date | 05-06-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.06 |
| Revenue | ★ $32,032,000.00 | N/A |
| Revenue This Year | $33.60 | $84.47 |
| Revenue Next Year | $30.40 | $39.32 |
| P/E Ratio | ★ N/A | $4.82 |
| Revenue Growth | ★ 27.20 | N/A |
| 52 Week Low | $4.16 | $0.14 |
| 52 Week High | $8.30 | $1.92 |
| Indicator | ECOR | ATCH |
|---|---|---|
| Relative Strength Index (RSI) | 62.81 | 51.80 |
| Support Level | $4.55 | $0.25 |
| Resistance Level | $7.50 | $0.29 |
| Average True Range (ATR) | 0.48 | 0.03 |
| MACD | 0.08 | -0.00 |
| Stochastic Oscillator | 87.25 | 38.37 |
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.